Baby :: Umbilical cord clamping should be delayed for 3 minutes after birth
Clamping and cutting of the umbilical cord should be delayed for three minutes after birth, particularly for pre-term infants, suggests a senior doctor in this week?s BMJ.
Clamping and cutting of the umbilical cord should be delayed for three minutes after birth, particularly for pre-term infants, suggests a senior doctor in this week?s BMJ.
A group of researchers from the University of Michigan Health System has been awarded a $6 million federal grant to study the serious injuries that afflict millions of women as a result of childbirth.
Few older women were interested in being tested for the virus that causes AIDS despite having significant risk factors for lifetime exposure, according to a study published in the July/August edition of the Journal of Women?s Health.
Risk of a common vaginal infection linked to preterm birth appears to escalate when even one partner is African-American, according to a University of Pittsburgh School of Medicine study presented today at the 34th annual meeting of the Infectious Diseases Society for Obstetrics and Gynecology in Boston.
Virginia Commonwealth University researchers have found that intrauterine devices are safe and effective in a population of women previously not considered as good candidates for this method of birth control.
A noninvasive, outpatient treatment for noncancerous uterine tumors provides sustained relief from symptoms, according to a new Mayo Clinic led collaborative study.
Progesterone therapy does not reduce the chances of preterm birth in women pregnant with twins, reported researchers in a network sponsored by the National Institutes of Health.
A new study from Massachusetts General Hospital (MGH) researchers confirms that female mice that receive bone marrow transplantation after fertility-destroying chemotherapy can go on to have successful pregnancies throughout their normal reproductive life.
Synova Healthcare Group, Inc. announced that the Today(r) Sponge, the first and only female contraceptive to combine a spermicide with a barrier contraceptive, is unveiling its exciting new look this summer.
A noninvasive, outpatient treatment for noncancerous uterine tumors provides sustained relief from symptoms, according to a new Mayo Clinic led collaborative study.